Tralokinumab: Exploring the Potential of LP 0162 and CAT-354 Tralokinumab, previously known as LP 0162 and CAT-354, represents a significant therapy for chronic dermatitis. This humanized antibody blocks IL-13, https://jasperjaxs197611.wikipresses.com/7494628/text